Evercore ISI started coverage on shares of Agilent Technologies (NYSE:A) in a report published on Wednesday morning. The brokerage issued an outperform rating and a $75.00 price target on the medical research company’s stock.
A has been the topic of a number of other research reports. Zacks Investment Research raised shares of Agilent Technologies from a hold rating to a buy rating and set a $76.00 target price on the stock in a report on Tuesday, October 31st. Robert W. Baird reaffirmed a buy rating and set a $70.00 target price on shares of Agilent Technologies in a report on Friday, October 20th. Cowen reaffirmed a hold rating and set a $65.00 target price on shares of Agilent Technologies in a report on Thursday, September 28th. ValuEngine lowered shares of Agilent Technologies from a buy rating to a hold rating in a report on Friday, December 1st. Finally, JPMorgan Chase & Co. upped their target price on shares of Agilent Technologies to $75.00 and gave the stock an overweight rating in a report on Tuesday, November 21st. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $68.78.
Shares of Agilent Technologies (NYSE:A) opened at $69.90 on Wednesday. Agilent Technologies has a 12-month low of $46.35 and a 12-month high of $70.93. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. The stock has a market cap of $22,500.00, a P/E ratio of 33.44, a PEG ratio of 2.10 and a beta of 1.28.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s payout ratio is currently 28.71%.
In other Agilent Technologies news, SVP Jacob Thaysen sold 22,583 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $70.41, for a total value of $1,590,069.03. Following the completion of the transaction, the senior vice president now owns 63,042 shares of the company’s stock, valued at approximately $4,438,787.22. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Mark Doak sold 15,567 shares of the business’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $68.00, for a total transaction of $1,058,556.00. Following the completion of the transaction, the insider now directly owns 71,104 shares of the company’s stock, valued at approximately $4,835,072. The disclosure for this sale can be found here. In the last three months, insiders sold 132,588 shares of company stock valued at $9,186,710.
Institutional investors have recently made changes to their positions in the company. Dupont Capital Management Corp purchased a new stake in shares of Agilent Technologies in the 3rd quarter valued at $101,000. Balentine LLC boosted its stake in shares of Agilent Technologies by 2.9% in the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after purchasing an additional 50 shares in the last quarter. Sun Life Financial INC boosted its stake in shares of Agilent Technologies by 26,144.4% in the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC boosted its stake in shares of Agilent Technologies by 92.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Fiduciary Trust Co. purchased a new stake in shares of Agilent Technologies in the 2nd quarter valued at $186,000.
ILLEGAL ACTIVITY WARNING: “Agilent Technologies (A) Earns Outperform Rating from Analysts at Evercore ISI” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3127961/agilent-technologies-a-earns-outperform-rating-from-analysts-at-evercore-isi.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.